| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/22/2012 | EP1095183B1 Methods for the diagnosis and treatment of lung cancer |
| 02/22/2012 | CN102358901A Antitumor application of has-miR-520e |
| 02/22/2012 | CN101805749B 基于vsig4的模拟病毒及其制备方法和应用 Simulation-based vsig4 virus and its preparation method and application |
| 02/22/2012 | CN101747451B 一种靶向粘附壳聚糖材料及其应用 Which targets the adhesion of chitosan materials and their applications |
| 02/22/2012 | CN101683354B 一种肝损伤相关的药物靶点及其应用 One kind of liver injury associated with drug targets and its application |
| 02/22/2012 | CN101648023B Dna与纳米层状羟基磷灰石复合物及其制备方法和应用 Dna and nano-layered hydroxyapatite compound and preparation method and application |
| 02/22/2012 | CN101362802B Dna依赖蛋白激酶催化亚基单链抗体及其编码基因与应用 Dna-dependent protein kinase catalytic subunit of single-chain antibody and its coding gene and application |
| 02/21/2012 | US8119791 si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation |
| 02/21/2012 | US8119789 Method for the production of a cell and/or tissue and/or disease phase specific medicament |
| 02/21/2012 | US8119766 Increasing functional glycosylation of alpha-dystroglycan in the treatment of muscle degeneration |
| 02/21/2012 | US8119611 Treatment of neurodegenerative disease through intracranial delivery of SIRNA |
| 02/21/2012 | US8119610 Methods of making RNAi libraries using E. coli RNAse III for inhibition of mammalian gene expression |
| 02/21/2012 | US8119609 Apoptosis and increased production of ceramides and DAG are normalized in the presence of antioxidants |
| 02/21/2012 | US8119608 Specific inhibition of expression of target gene in mammals using short double stranded RNA; dsRNA less than 49 nucleotides in length, has nucleotide sequence complementary to part of target gene; treating cancer, Alzheimer's disease |
| 02/21/2012 | US8119590 Apolipoprotein A-I (ApoA-I), preferably a variant form such as Apolipoprotein A-I Milano (ApoA-IM), alone or more preferably in combination with a lipid carrier such as phospholipids or other drug, can be administered locally |
| 02/21/2012 | US8119405 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 02/21/2012 | US8119401 IL-10 gene transfer to peripheral mononuclear cells |
| 02/21/2012 | US8119400 Methods of inhibiting smooth muscle cell migration and proliferation |
| 02/21/2012 | US8119396 Recombinant adenoviral vectors and applications thereof |
| 02/21/2012 | US8119395 Vaccines, immunotherapeutics and methods for using the same |
| 02/21/2012 | US8119119 Retroviral vector for improving exogenous gene transfer and expression in cells |
| 02/21/2012 | US8119118 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 02/21/2012 | US8119117 Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity |
| 02/21/2012 | CA2568995C Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 02/21/2012 | CA2407680C Dendritic cell co-stimulator molecules |
| 02/21/2012 | CA2398940C Methods and compositions using stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 02/21/2012 | CA2373300C Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 02/21/2012 | CA2349760C Bovine cells expressing adeno virus essential functions for propagation of recombinant adenoviral vectors |
| 02/21/2012 | CA2322055C Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 02/21/2012 | CA2302866C Genetically modified tumor-targeted bacteria with reduced virulence |
| 02/21/2012 | CA2297303C Novel peptides and polypeptides useful for regenerating the nervous system |
| 02/21/2012 | CA2296841C Tropoelastin derivatives |
| 02/21/2012 | CA2269085C Rainbow trout il1.beta.; encoding nucleic acid; materials and methods |
| 02/21/2012 | CA2264592C Bioconjugates and delivery of bioactive agents |
| 02/21/2012 | CA2263835C Stimulus-inducible i (kappa)b kinase [ikk] signalsome |
| 02/21/2012 | CA2158936C Compositions and methods for utilizing conditionally lethal genes |
| 02/16/2012 | WO2012021891A2 Compositions, kits and methods for treatment of complement-related disorders |
| 02/16/2012 | WO2012021735A2 Pharmaceutical products from gungal strains |
| 02/16/2012 | WO2012021383A2 RNA INTERFERENCE MEDIATED INHIBITION OF MITOGEN-ACTIVATED PROTEIN KINASE 1 (MAPK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/16/2012 | WO2012021165A2 Methods and compositions for treating disorders associated with hyperactive immune system |
| 02/16/2012 | WO2012020836A1 Therapeutic agent for hepatitis c containing rrm2 antagonist as active ingredient |
| 02/16/2012 | WO2012020795A1 Nucleic acid/polysaccharide complex |
| 02/16/2012 | WO2012020001A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject |
| 02/16/2012 | WO2012007632A9 Use of edg2 inhibitors for treating rheumatoid arthritis |
| 02/16/2012 | WO2010107740A8 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 02/16/2012 | US20120042399 Immunogenic peptides |
| 02/16/2012 | US20120041176 Ucp4 |
| 02/16/2012 | US20120041050 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 02/16/2012 | US20120040909 Identification of novel antagonist toxins of t-type calcium channel for analgesic purposes |
| 02/16/2012 | US20120040829 Bacterial ghosts as carrier and targeting vehicles |
| 02/16/2012 | US20120039986 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2 |
| 02/16/2012 | US20120039938 Composition comprising the polyprotein ns3/ns4 and the polypeptide ns5b of hcv, expression vectors including the corresponding nucleic sequences and their therapeutic use |
| 02/16/2012 | US20120039931 Dna composition encoding an immunogenic vegf receptor peptide and methods of use thereof |
| 02/16/2012 | US20120039914 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor |
| 02/16/2012 | US20120039909 Epigenetic mechanisms re-establish access to long-term memory after neuronal loss |
| 02/16/2012 | US20120039905 The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection |
| 02/16/2012 | US20120039858 Methods and compositions for inhibiting propagation of viruses using recombinant tetherin constructs |
| 02/16/2012 | US20120039798 Methods of modifying p53 acetylation and treating cancer using avra |
| 02/16/2012 | CA2807628A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject |
| 02/15/2012 | EP2418281A2 Methods and compositions for delivering polynucleotides |
| 02/15/2012 | EP2417985A1 Mitochondrial function-improving agent |
| 02/15/2012 | EP2417259A1 Neuron generation, regeneration and protection |
| 02/15/2012 | EP2416762A2 Controlled release devices and methods for delivery of nucleic acids |
| 02/15/2012 | EP1951891B1 Cancer antigen mage-a9 and uses thereof |
| 02/15/2012 | EP1532161B1 Vectors for expression of hml-2 polypeptides |
| 02/15/2012 | CN102355911A Use of vgii3 activity modulator for the modulation of adipogenesis |
| 02/15/2012 | CN102355910A Composition for improving inflammatory disease using abh antigens |
| 02/15/2012 | CN102352368A ING4 and OSM double-gene co-expression vector and application thereof |
| 02/15/2012 | CN102352358A Seventy-four rat source miRNA (ribonucleic acid) as well as corresponding miRNA precursor and antisense oligonucleotide thereof |
| 02/15/2012 | CN102352356A Bcl11a siRNA-2292 restraining expression of BCL11A and proliferation of tumorous B cells and application thereof |
| 02/15/2012 | CN102352355A Compositions and methods for short interfering nucleic acid inhibition of NAv1.8 |
| 02/15/2012 | CN102351932A Structure, preparation method and purpose of anti-influenza virus oligonucleotide |
| 02/15/2012 | CN102350001A Preparation method of heterologous bluetongue virus double-strand RNA (ribonucleic acid) endogenous interferon inducer |
| 02/15/2012 | CN102350000A Application of heterogeneous bluetongue virus dsRNA (double-strand ribonucleic acid) in preparation of endogenic interferon inducer |
| 02/15/2012 | CN102349997A Diagnosis and prevention of cancer cell invasion |
| 02/15/2012 | CN101721711B 邻菲咯啉钌环糊精-金刚烷芘-单壁碳纳米管三元超分子体系的制备方法及应用 Phenanthroline ruthenium cyclodextrin - adamantane pyrene - single-walled carbon nanotube preparation and application of ternary supramolecular system |
| 02/15/2012 | CN101475503B 一种新型阳离子类脂及其制备方法和应用 A novel cationic lipid and its preparation method and application |
| 02/14/2012 | US8114981 Method and medicament for inhibiting the expression of a given gene |
| 02/14/2012 | US8114971 Nucleotide sequences coding gramnegative bacterial lipoprotein for use in prevention and treatment of microorganismal infection; genetic vaccine |
| 02/14/2012 | US8114965 Compositions of PSMA antibodies |
| 02/14/2012 | US8114852 N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 02/14/2012 | US8114851 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 02/14/2012 | US8114849 Retinal dystrophy-associated protein and uses thereof |
| 02/14/2012 | US8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 |
| 02/14/2012 | US8114637 Packaging cells for recombinant adenovirus |
| 02/14/2012 | US8114603 collecting a blood sample from the subject; andmeasuring the levels of Triggering Receptor Expressed on Myeloid cells (TREM-1) splice variant protein in sample, a decrease in the levels of TREM-1 splice variant indicates an inflammatory response |
| 02/14/2012 | US8114601 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 02/14/2012 | US8114416 Modified oncolytic viruses |
| 02/14/2012 | US8114404 Method and composition for altering a B cell mediated pathology |
| 02/14/2012 | US8114401 Chlamydia trachomatis antigens |
| 02/14/2012 | CA2402160C Heparinase iii and uses thereof |
| 02/14/2012 | CA2343135C Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 02/09/2012 | WO2012019188A2 Methods and compositions for the inhibition of fructokinase |
| 02/09/2012 | WO2012019184A2 Compositions and methods for detecting, diagnosing, and treating cancer |
| 02/09/2012 | WO2012019154A2 Methods and compositions for malic enzyme 2 (me2) as a target for cancer therapy |
| 02/09/2012 | WO2012019121A2 Multiplexed supramolecular assemblies for non-viral delivery of genetic material |
| 02/09/2012 | WO2012019060A1 Predicting and treating diabetic complications |
| 02/09/2012 | WO2012018881A2 Methods and compositions for the regulation of rna |
| 02/09/2012 | WO2012018877A2 Treating breast cancer with anti-il-19 antibody |
| 02/09/2012 | WO2012018866A2 Methods and compositions for the diagnosis and treatment of breast cancer |